Agilent Technologies, Inc. - Diagnostics and Genomics BL21(DE3) pLysS Comp Cells 5 x 0.2 ml
Agilent's BL21(DE3) pLysS Competent Cells are designed for high-level protein expression using T7 RNA polymerase-based systems. These E. coli cells carry the pLysS plasmid, which expresses T7 lysozyme to reduce basal expression of T7 RNA polymerase, making them suitable for cloning and expressing potentially toxic proteins. The cells are provided in a convenient 5 x 0.2 ml format, ensuring high transformation efficiency and reproducibility. They are ideal for use with T7 promoter-driven expression vectors and are compatible with a wide range of protein expression applications in molecular biology research.